apo-fentanyl fentanyl 75 micrograms/hour transdermal drug delivery system sachet
sandoz pty ltd - fentanyl, quantity: 12.6 mg - drug delivery system, transdermal - excipient ingredients: polyethylene terephthalate; ethyl acetate; 2-ethylhexyl acrylate; vinyl acetate; 2,2'-azobisisobutyronitrile; 2-hydroxyethyl acrylate - for the management of pain associated with cancer, palliative cancer and other conditions in patients where: - other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and - the pain is opioid-responsive, and - severe enough to require daily, continuous long term opioid treatment. not for use in opioid-naive patients.
fentanyl sandoz fentanyl 25 micrograms/hour transdermal drug delivery system sachet
sandoz pty ltd - fentanyl, quantity: 4.2 mg - drug delivery system, transdermal - excipient ingredients: polyethylene terephthalate; ethyl acetate; 2-ethylhexyl acrylate; vinyl acetate; 2,2'-azobisisobutyronitrile; 2-hydroxyethyl acrylate - for the management of pain associated with cancer, palliative cancer and other conditions in patients where: - other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and - the pain is opioid-responsive, and - severe enough to require daily, continuous long term opioid treatment. not for use in opioid-naive patients.
fentanyl sandoz fentanyl 75 micrograms/hour transdermal drug delivery system sachet
sandoz pty ltd - fentanyl, quantity: 12.6 mg - drug delivery system, transdermal - excipient ingredients: polyethylene terephthalate; ethyl acetate; 2-ethylhexyl acrylate; vinyl acetate; 2,2'-azobisisobutyronitrile; 2-hydroxyethyl acrylate - for the management of pain associated with cancer, palliative cancer and other conditions in patients where: - other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and - the pain is opioid-responsive, and - severe enough to require daily, continuous long term opioid treatment. not for use in opioid-naive patients.
defodin mouthwash 1%w/v solution
al ittihad drug store saudi arabia - 200ml bottle - solution - 1%w/v - ear nose , oropharynx-oropharynx
defadine surgical scrub 7.5%w/v solution
al ittihad drug store saudi arabia - 200ml bottle - solution - 7.5%w/v - skin-disinfectants
cytarose solution combination liquid
al ittihad drug store saudi arabia - 250ml bottle - liquid - combination - nutrition , blood-oral nutrition
defodin vaginal douche 10%w/v solution
al ittihad drug store saudi arabia - 200ml bottle - solution - 10%w/v - obstetrics,gynaecology,urinary-tract-vaginal , vulval conditions
hemamax 50mg / 5ml syrup
al ittihad drug store saudi arabia - 100 ml bottle - syrup - 50mg / 5ml - nutrition , blood-anaemia , other blood disorders
binosto® 70mg 70mg/tablet
al ittihad drug store switzerland - 4 effervescent tablets - tablet - 70mg/tablet - endocrine system-drugs affecting bone metabolism
bonyl plus combination tablet
al ittihad drug store turkey - 4's blister - tablet - combination - endocrine system-drugs affecting bone metabolism